135 related articles for article (PubMed ID: 6372081)
1. Gold in rheumatoid arthritis therapy today. Late or never?
Olhagen B
Scand J Rheumatol Suppl; 1983; 51():120-1. PubMed ID: 6372081
[No Abstract] [Full Text] [Related]
2. [Effect of anti-rheumatic agents on liver cell function in patients with rheumatoid arthritis].
Schubotz R; Dickmann R; Massarrat S
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():709-11. PubMed ID: 1029269
[No Abstract] [Full Text] [Related]
3. [Rheumatoid factors during controlled krizanol treatment of rheumatoid arthritis patients].
Alekberova ZS; Trofimova TM; Speranskiĭ AI; Beresten' TI
Revmatologiia (Mosk); 1985; (3):19-22. PubMed ID: 3903922
[No Abstract] [Full Text] [Related]
4. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
Stein HB; Ruedy J; Atkins CJ; Offer RC
Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
[TBL] [Abstract][Full Text] [Related]
5. [Chrysotherapy in rheumatoid arthritis].
Ouaknine L; Machtey I
Harefuah; 1972 Apr; 82(8):375-6. PubMed ID: 5050689
[No Abstract] [Full Text] [Related]
6. Gold in rheumatoid arthritis therapy today. Early treatment.
Luukkainen R
Scand J Rheumatol Suppl; 1983; 51():118-9. PubMed ID: 6372080
[No Abstract] [Full Text] [Related]
7. Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions.
Reychler R; De Geeter T; Verbruggen LA
Clin Rheumatol; 1986 Jun; 5(2):275-7. PubMed ID: 3731724
[No Abstract] [Full Text] [Related]
8. [Study on the nephrotoxicity of antirheumatic drugs. II. Effect of gold salts on the levels of enzymes in the urine].
Trnavský K; Rovenský J
Fysiatr Revmatol Vestn; 1974 Apr; 52(2):113-6. PubMed ID: 4857510
[No Abstract] [Full Text] [Related]
9. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
Franchimont P; Heynen G; Hauwaert CH
J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
[TBL] [Abstract][Full Text] [Related]
10. Treating joint inflammation in the elderly: an update.
Ziminski CM
Geriatrics; 1985 Jan; 40(1):73-81, 85, 88. PubMed ID: 3965357
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy in the management of rheumatoid arthritis.
Roumm A; Buckingham RB
Compr Ther; 1983 Sep; 9(9):20-6. PubMed ID: 6627901
[No Abstract] [Full Text] [Related]
12. [Prophylaxis and therapeutics of iatrogenic consequences, produced by treatment of rheumatoid arthritis (author's transl)].
Vanslype J; Tritsmans E; Verstraete J
Acta Rhumatol Belg; 1978; 2(1-2):22-33. PubMed ID: 751468
[No Abstract] [Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs.
O'Brien WM
Pharmacology; 1982; 25 Suppl 1():1-8. PubMed ID: 7111378
[No Abstract] [Full Text] [Related]
14. Choice of drugs in the treatment of rheumatoid arthritis.
Hart D
J R Coll Gen Pract; 1969 Nov; 18(88 Suppl 3):7-11. PubMed ID: 5351015
[No Abstract] [Full Text] [Related]
15. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters.
Lund B; Graae A; Sonne I; Andersen RB
Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis therapy: the risk/benefit ratio.
Bellows JG
Compr Ther; 1978 Aug; 4(8):3-4. PubMed ID: 308431
[No Abstract] [Full Text] [Related]
17. [Current therapy of rheumatoid arthritis].
Sigidin IaA
Klin Med (Mosk); 1983 May; 61(5):105-11. PubMed ID: 6876694
[No Abstract] [Full Text] [Related]
18. [Long-term clinical follow-up studies of basic therapy in rheumatoid arthritis].
Piaĭ LT
Ter Arkh; 1981; 53(7):67-9. PubMed ID: 7292319
[No Abstract] [Full Text] [Related]
19. [Indications and contraindications for systemic gold therapy].
Schattenkirchner M
Wien Klin Wochenschr Suppl; 1984; 156():3-7. PubMed ID: 6442054
[TBL] [Abstract][Full Text] [Related]
20. Gold in rheumatoid arthritis therapy today. Dosage.
Husby G
Scand J Rheumatol Suppl; 1983; 51():122-4. PubMed ID: 6426046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
